N/A
Manufactured by Immunex Corporation
1,364,746 FDA adverse event reports analyzed
Last updated: 2026-05-19
Enbrel is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Immunex Corporation. The most commonly reported adverse reactions for Enbrel include DRUG INEFFECTIVE, INJECTION SITE PAIN, RHEUMATOID ARTHRITIS, ARTHRALGIA, PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for Enbrel.
Out of 592,873 classified reports for Enbrel:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 1,364,746 FDA FAERS reports that mention Enbrel. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, INJECTION SITE PAIN, RHEUMATOID ARTHRITIS, ARTHRALGIA, PAIN, INJECTION SITE ERYTHEMA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Immunex Corporation in connection with Enbrel. Always verify the specific product and NDC with your pharmacist.
Explore other medications manufactured by Immunex Corporation and compare their safety profiles:
The following drugs share commonly reported adverse reactions with Enbrel: